Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer.
Antonio RaffoneAntonio TravaglinoOlimpia GabrielliMariacarolina MicheliValeria ZuccalàGiovanna BitontiCaterina CamastraValentina GargiuloLuigi InsabatoFulvio ZulloPublished in: Archives of gynecology and obstetrics (2021)
The ProMisE groups identify different phenotypes of patients. The POLE-mt group included the youngest women, with the lower BMI and the highest prevalence of stage I. The p53-wt group included patients with the highest BMI. The p53-abn group included the oldest women, with the highest prevalence of adjuvant treatment and the lowest prevalence of stage I. The MMR-d group showed intermediate values among the ProMisE groups for all clinical features.